| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
October 25, 2022 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2022 -10-26
Imaging holds great promise for clinical trials in all phases. In early phase trials it can provide a direct window into drug effects, proving or disproving the mechanism of action while detecting if there is an efficacy signal. For registration trials it is the quickest path to the pharmacy shelf.
In this webinar, attendees will learn how Philips Pharma Solutions, formerly BioTel Research, applies more than 20 years of imaging science and operational expertise to identify and manage the inherent risks to capturing complete and high-quality central review data of study endpoints, unlocking its full potential.
Register to understand the importance of imaging and the best practices to support successful central review of data to prove endpoint.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Ed Ashton, Vice President of Oncology Imaging, Philips Pharma Solutions Alan Soanes, Director of Feasibility, Philips Pharma Solutions
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2022 -10-26
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|